Cellebrite DI Ltd.

CLBTNASDAQTechnology● Active

$13.43

$-0.38(-2.75%)

Market Cap$3.3B

P/E Ratio—

52W High$19.98

52W Low$11.02

Avg Volume2.0M

Open$13.79

Beta1.17

Free Cash Flow Financials Revenue

Cellebrite DI Ltd. (CLBT) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CLBT · free cash flow · updated Jun 8, 2026

Core FCF metrics

CLBT · FCF · TTM · margin & CAGR

Free cash flow was $155.7M for FY2025 (fiscal year ending 2025-12-31), up 28.1% year-over-year The FCF margin was 32.7%. Five-year CAGR stands at +20.9%.

FY2025 Free Cash Flow$155.7M▲ +28.1% YoY

Trailing 12M (TTM)$154.0Mtrailing 4 quarters sum

FCF Margin32.7%$155.7M ÷ revenue

3-Year CAGR+138.4%FY2022 → FY2025

5-Year CAGR+20.9%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CLBT · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$169.0M(13M)$155.7M▲ +28.1%32.7%

FY2024$132.2M(11M)$121.6M▲ +29.1%30.3%

FY2023$102.1M(8M)$94.1M▲ +719.2%29.0%

FY2022$20.6M(9M)$11.5M▼ 58.9%4.3%

FY2021$36.1M(8M)$27.9M▼ 53.7%11.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CLBT · P/FCF · FCF yield · FCF per share

Cellebrite DI Ltd. (CLBT) trades at a FCF yield of 4.52% and a price-to-free-cash-flow ratio of 22.0x. FCF per share stands at $0.61, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

4.52%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.61

TTM FCF ÷ Shares Outstanding

Price / FCF

x22.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x21.4

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CLBT · cash flow statement · operating / investing / financing

For FY2025, Cellebrite DI Ltd. generated $169.0M in operating cash flow and spent 13M in capital expenditures, yielding $155.7M in free cash flow.

Operating Activities

+$169.0M

Cash from core business operations

2025-12-31

Investing Activities

−$268.3M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$29.6M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($169.0M) − |CapEx| (13M) = FCF ($155.7M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Technology)

CLBT vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Cellebrite DI Ltd.YOU

CLBT

$155.7M+28.1%32.7%

Taiwan Semiconductor Manufacturing Company Limited

Microsoft Corporation

Technology · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Cellebrite DI Ltd. (CLBT) reported free cash flow of $155.7M for FY2025 (fiscal year ending 2025-12-31), up 28.1% year-over-year. The FCF margin was 32.7%.

Based on available data, Cellebrite DI Ltd. has maintained positive free cash flow for at least 7 fiscal year(s). FCF peaked at $155.7M in FY2025. The 5-year CAGR stands at +20.9%.

Cellebrite DI Ltd.'s FCF yield is 4.52% and price-to-FCF ratio is 22.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CLBT free cash flow · 8 questions

Cellebrite DI Ltd. free cash flow was $155.7M for FY2025, up 28.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $154.0M.

CLBT free cash flowCLBT FCFCLBT FCF 2025CLBT free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Cellebrite DI Ltd. · Cellebrite DI Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026